UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 orOR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~January~~March 813, 2020

Natur International Corp.

(Exact name of registrant as specified in its charter)

Wyoming

000-54917

45-5547692

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

Parnassus Tower Locatellikade 1 1076 AZ Amsterdam The Netherlands		N/A
(Address of principal executive offices)		(Zip Code)

Parnassus Tower

Locatellikade 1

1076 AZ Amsterdam

The Netherlands

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +31 20 578 7700

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name on exchange on which registered None - -

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item~~Securities ~~5.02~~registered ~~Departure~~pursuant ofto ~~Directors~~Section ~~or Certain Officers; Election~~ 12(b) of ~~Directors;~~the ~~Appointment of Certain Officers, Compensation Arrangements of Certain Officers~~Act:

OnTitle ~~January 8, 2020, Paul Bartley resigned as a director and as Co-Chief Executive Officer~~ of ~~Natur~~each ~~International~~class ~~Corp.~~Trading Symbol(~~the “Company”~~s). ~~Mr.~~Name ~~Bartley~~on ~~will~~exchange ~~remain with the Company and will focus~~ on ~~development~~which ofregistered ~~our~~None ~~joint~~- ~~venture with WRH Industries, Ltd., described in Item 8.01 below.~~-

OnItem ~~January 9, 2020, the Company’s Board of Directors appointed Spencer Chesman, the Company’s Co-Chief Executive Officer, as sole Chief Executive Officer of the Company~~8.01 ~~Mr. Chesman is also a director of the Company. The information concerning Mr. Chesman set forth in the Company’s Current Report on Form 8~~-K ~~filed~~Other ~~with the Securities and Exchange Commission on November 15, 2019, is incorporated herein by reference~~Events.

~~Item~~Application ~~8.01~~for ~~Other~~a ~~Events~~45-days extension of the filing deadline of the 10-K.

WeNatur ~~have~~International ~~entered~~Corp. ~~into~~(“natur” or athe ~~joint~~company) ~~venture~~seeks ~~with~~an ~~WRH~~extension of 45 days to file its annual report on Form 10-K, for the fiscal year ended December 31, 2019, ~~Industries~~based on the SEC Order under Section 36 of the Exchange Act, ~~Ltd~~set forth in Release No. 34-88318, aissued ~~leader~~March in4, 2020, which authorizes the ~~design~~Commission ~~and~~to ~~manufacture~~exempt, either conditionally or unconditionally, any person, security or transaction, or any class or classes of ~~plastic~~persons, ~~molds~~securities, ~~containers~~or transactions, ~~packaging~~from ~~and~~any ~~other~~provision ~~products~~or ~~for~~provisions ~~industry~~of the Exchange Act or any rule or regulation thereunder, to ~~market~~the ~~molds~~extent that such exemption is necessary or appropriate in the public interest, and ~~trays~~is toconsistent ~~manufacturers~~with ofthe ~~CBD-infused~~protection ~~products~~of investors.

1 On November 11, 2019, the company announced a merger with Share International, which has its operations in the Peoples’ Republic of China. The closing of this transaction, originally planned for midst of February 2020, is delayed due to the circumstances in China caused by the COVID-19 virus. Share International is currently not able to deliver the closing documents and financial records of its China activities due to illness of some key employees. As this transaction was announced to the public by form of press release on November 11, 2019, the company is obliged to inform the public in its 10-K, as a subsequent event, about the materiality of the transaction and to publish the (unaudited) results of the 4th quarter 2019 of Share International, which are part of the required closing documents. With its head office in the Netherlands and having a Chinese Financial Director, the company itself is also hit by absences of staff due to the effects of the COVID-19 virus, causing a material slow-down of the activities needed to finalize the audited financial statements of the year 2019.

~~SIGNATURES~~The company expects to file its annual report within the time frame of the extension, on or before May 14, 2020.

~~Pursuant~~Attached tois a signed statement from Mr. Zeng Li, the ~~requirements~~CEO of Share International and the ~~Securities~~Chinese activities, who is located in Chongqing, PRC, which confirms that due to ~~Exchange~~the ~~Act~~illness of ~~1934,~~several staff members of the ~~registrant~~local ~~has~~enterprise ~~duly~~and ~~caused~~the ~~this~~fact ~~report~~that the office was closed in the early part of 2020 and continues to be ~~signed~~understaffed, onit ~~its~~has ~~behalf~~not bybeen able to provide the ~~undersigned~~financial ~~hereunto~~information ~~duly~~to ~~authorized~~the company for its completion of its financial reporting.

	Natur International Corp.
Date: January 14, 2020	By:	/s/ Spencer Chesman
	Name:	Spencer Chesman
	Title:	Chief Executive Officer

Risk Factor

2 It is to be expected that the operations of Share International will be negatively impacted due to understaffing, and a significant decrease of consumer demands in Chongqing. We expect that as the Covid-19 Virus expands as a pandemic and state actions are taken that are disrupting commerce at all levels of industry, there will be various adverse effects experienced by companies such as ours that deal in consumer products and services Although the company and Share International are taking measures to mitigate the effect as much as possible there is no assurance that the steps will be sufficient. In most respects it is too early in the pandemic to be able to quantify all the ramifications.

Although the company is confident that filing will take place within the timeline of the extension, this is not a certainty as local in the locations from where require information for our reporting circumstances may change for the worse.

Item 9.01 — Financial Statements and Exhibits

(d) Exhibits

Exhibit No.		Description

99.1		Letter from Mr. Zeng Li of Share International relating to delays in reporting caused by Covid 19.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Natur International Corp.

Date: March 13, 2020	By:	/s/ Ruud Huisman
	Name:	Ruud Huisman
	Title:	Chief Financial Officer

Filing Compare · Natur International Corp.